Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Special Issue: Current evidence and perspectives for hypertension management in Asia
  • Published:

Hypertension combined with atherosclerosis increases the risk of heart failure in patients with diabetes

Abstract

The increase in heart failure risk in the diabetic population when hypertension and atherosclerosis are both present is still inconclusive. The aim of this study was to explore the effects of hypertension combined with atherosclerosis in diabetic population on the risk of heart failure. We selected 10,711 patients with diabetes who participated in the Kailuan study and completed brachial-ankle pulse wave velocity (baPWV) testing for statistical analysis. The subjects were divided into the non-hypertensive non-atherosclerotic, hypertensive, atherosclerotic, and hypertensive atherosclerotic groups based on their history of hypertension and atherosclerosis. At a median follow-up of 4.15 years, 227 cases of heart failure occurred. Compared with the non-hypertensive non-atherosclerotic group, the multifactorial Cox proportional risk regression model showed that the hazard ratio (HR) for heart failure in the hypertensive atherosclerotic group was 3.08 (95% confidence interval [CI]: 1.32–7.16), whereas the HR decreased to 2.38 (95% CI: 1.01–5.63) after gradual correction of lipid-lowering, glucose-lowering, and antihypertensive drugs. The subgroup analysis and sensitivity analysis were consistent with that of total population. In conclusion, patients with diabetes exposed to both hypertension and atherosclerosis had an increased heart failure risk, which was attenuated by the use of lipid-lowering, glucose-lowering, and antihypertensive drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21:1329–37.

    PubMed  Google Scholar 

  2. Wang H, Chai K, Du M, Wang S, Cai J, Li Y, et al. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis. Circ Heart Fail. 2021;14:e008406.

    PubMed  Google Scholar 

  3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–e220.

    PubMed  Google Scholar 

  4. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Kannel WB, McGee DL. Diabetes and cardiovascular disease, The Framingham study,. JAMA. 1979;241:2035–8.

    CAS  PubMed  Google Scholar 

  6. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891–7.

    CAS  PubMed  Google Scholar 

  7. Yasutaka M, Toyoshi I, Erina E, Yoshimi K, Shuji S, Noriyuki S, et al. Brachial-ankle pulse wave velocity predicts all-cause mortality and cardiovascular events in patients with diabetes: the Kyushu Prevention Study of Atherosclerosis. Diabetes Care. 2014;37:2383–90.

    Google Scholar 

  8. Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35:e3158.

    PubMed  Google Scholar 

  9. Wu SL, Huang ZR, Yang XC, Zhou Y, Wang AX, Chen L, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5:487–93.

    PubMed  Google Scholar 

  10. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.

    PubMed  Google Scholar 

  12. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72:2231–64.

    PubMed  Google Scholar 

  13. Ivanova SA. Application of Minnesota ECG classifification code system amplifified by some quantitative code signs, in diagnostics of acquired vitium cordis and early phase of ischemic heart disease. Adv. Cardiol. 1977;19:257–8.

    CAS  PubMed  Google Scholar 

  14. Chinese Joint Committee for the Revision of Guidelines for the Prevention and Treatment of dyslipidemia in adults. 2016 Chinese guideline for the management of dyslipidemia in adults, Chin. J Cardiol. 2016;44:833–853. (In Chinese)

    Google Scholar 

  15. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–57.

    CAS  PubMed  Google Scholar 

  16. Whelton PK, Carey RM, Aronow WS, Casey Jr DE, Collins KJ, Himmelfarb CD, et al. 2017ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–e115.

    CAS  PubMed  Google Scholar 

  17. Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association. Chinese heart failure association of chinese medical doctor association; editorial board of Chinese journar of cardioloy. the guidelines for diagnosis and treatment of heart failure in China in 2018 Chin J Heart Fail Cardio. 2018;4:196–225.

    Google Scholar 

  18. Niiranen TJ, Kalesan B, Hamburg NM, Benjamin EJ, Mitchell GF, Vasan RS. Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study. J Am Heart Assoc. 2016;5:e004271.

    PubMed  PubMed Central  Google Scholar 

  19. Wu YT, Zhang YJ, Gao JS, Man SL, Xing JN, Cao ZW, et al. Effect of brachial-ankle pulse wave velocity combined with blood pressure on cardio-cerebrovascular events. Exp Ther Med. 2019;18:4555–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Cholesterol Treatment Trialists’ (CTT) Collaborators, Kearney PM, BlackwellL, Collins R, Keech A, Simes J, Peto R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis,. Lancet. 2008;371:117–25.

    Google Scholar 

  21. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.

    PubMed  Google Scholar 

  22. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.

    PubMed  Google Scholar 

  23. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.

    CAS  PubMed  Google Scholar 

  24. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, et al. SPRINT Study Research Group. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention T rial (SPRINT). Clin Trials. 2014;11:532–46.

    PubMed  Google Scholar 

  25. Zhou YF, Wang Y, Wang G, Zhou Z, Chen S, Geng T, et al. Association Between Statin Use and Progression of Arterial Stiffness Among Adults With High Atherosclerotic Risk. JAMA. 2022;5:e2218323.

    Google Scholar 

  26. Zheng HW, Wu SL, Liu XK, Qiu GY, Chen SH, Wu YT, et al. Association Between Arterial Stiffness and New-Onset Heart Failure: The Kailuan Study. Arterioscler Thromb Vasc Biol. 2023;43:e104–e111.

    CAS  PubMed  Google Scholar 

  27. Sung MK, Gyeongsil L, Seulggie C, Kim K, Jeong SM, Son JS, et al. Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality. Diabetologia. 2020;63:2305–14.

    Google Scholar 

  28. Hu C, Lin L, Zhu Y, Zhang Y, Wang S, Zhang J, et al. Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study. Front Endocrinol (Lausanne). 2021;12:717069.

    PubMed  Google Scholar 

  29. Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality. J Am Coll Cardiol. 2020;75:2921–30.

    PubMed  Google Scholar 

  30. Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6:279–86.

    PubMed  Google Scholar 

  31. Pagidipati NJ, Zheng YG, Green JB, McGuire DK, Mentz RJ, Shah S, et al. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. Am Heart J. 2020;219:47–57.

    PubMed  Google Scholar 

  32. Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, et al. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab. 2014;16:317–25.

    CAS  PubMed  Google Scholar 

  33. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–70.

    PubMed  Google Scholar 

  34. Vestberg D, Rosengren A, Olsson M, Gudbjörnsdottir S, Haraldsson B, Svensson AM, et al. Decreased eGFR as a Risk Factor for Heart Failure in 13 781 Individuals With Type 1 Diabetes. J Diabetes Sci Technol. 2015;10:131–6.

    PubMed  PubMed Central  Google Scholar 

  35. Tancredi M, Rosengren A, Olsson M, Gudbjörnsdottir S, Svensson AM, Haraldsson B, et al. The relationship between three eGFR formulas and hospitalization for heart failure in 54 486 individuals with type 2 diabetes. Diabetes Metab Res Rev. 2016;32:730–5.

    CAS  PubMed  Google Scholar 

  36. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.

    CAS  PubMed  Google Scholar 

  37. Costa-Hong VA, Muela HCS, Macedo TA, Sales ARK, Bortolotto LA. Gender differences of aortic wave reflection and influence of menopause on central blood pressure in patients with arterial hypertension. BMC Cardiovasc Disord. 2018;18:123.

    PubMed  PubMed Central  Google Scholar 

  38. Lu Y, Pechlaner R, Cai J, Yuan H, Huang Z, Yang G, et al. Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. J Am Coll Cardiol. 2020;75:870–80.

    PubMed  Google Scholar 

  39. Saeed A, Kampangkaew J, Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 2017;13:185–92.

    PubMed  PubMed Central  Google Scholar 

  40. Chirinos J, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:1237–63.

    PubMed  PubMed Central  Google Scholar 

  41. Franz HM, Stefano FR, Sripal B. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC Heart Fail. 2017;5:543–51.

    Google Scholar 

  42. Sonia MR, Ana B, María S, Varona S, Palao T, Orriols M, et al. Lysyl oxidase induces vascular oxidative stress and contributes to arterial stiffness and abnormal elastin structure in hypertension:role of p38MAPK. Antioxid Redox Signal. 2017;27:379–97.

    Google Scholar 

  43. Hashimoto J, Westerhof BE, Westerhof N, Imai Y, O’Rourke MF. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J Hypertens. 2008;26:1017–24.

    CAS  PubMed  Google Scholar 

  44. Zamani P, Bluemke DA, Jacobs DR Jr, Duprez DA, Kronmal R, Lilly SM, et al. Resistive and pulsatile arterial load as predictors of left ventricular mass and geometry: the multi-ethnic study of atherosclerosis. Hypertension. 2015;65:85–92.

    CAS  PubMed  Google Scholar 

  45. Gillebert TC, Leite-Moreira AF, De Hert SG. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev. 2000;5:345–55.

    CAS  PubMed  Google Scholar 

  46. Chirinos JA. Large Artery Stiffness, Microvascular Function, and Cardiovascular Risk. Circ Cardiovasc Imaging. 2016;9:e005903.

    PubMed  PubMed Central  Google Scholar 

  47. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in Hypertension, A New Target for Treatment? Circulation. 2001;104:735–40.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all study participants, their relatives, the members of the survey teams at the 11 regional hospitals of the Kailuan Medical Group; and the project development and management teams at the Shanghai General Hospital and the Kailuan Group.

Funding

The work for this article was supported by National Natural Scientifc Funding of China (No 82070335 & No 81570293) and the National Key R&D Program (2020YFC2004703).

Author information

Authors and Affiliations

Authors

Contributions

LW conducted the statistical analysis, interpreted the data and drafted the manuscript. JG performed the experiments and interpreted the data. JZ revising the manuscript for intellectual content. MW, SC, GW and LH interpreted the data. Shouling Wu, and Jiang Hong had full access to all the data and take responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding authors

Correspondence to Shouling Wu or Jiang Hong.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, L., Gao, J., Zhuang, J. et al. Hypertension combined with atherosclerosis increases the risk of heart failure in patients with diabetes. Hypertens Res 47, 921–933 (2024). https://doi.org/10.1038/s41440-023-01529-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01529-y

Keyword

Search

Quick links